Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasms, Connective and Soft Tissue
×
Lymphoid
×
Clear all
Filters
3
NCT02602067
2018-09-18
Tenatumomab
sigma-tau i.f.r. S.p.A.
Phase 1
Terminated
2 enrolled